Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Increased plasma homocysteine levels in patients with multiple sclerosis and depression.
Triantafyllou N, Evangelopoulos ME, Kimiskidis VK, Kararizou E, Boufidou F, Fountoulakis KN, Siamouli M, Nikolaou C, Sfagos C, Vlaikidis N, Vassilopoulos D. Triantafyllou N, et al. Among authors: vlaikidis n. Ann Gen Psychiatry. 2008 Sep 9;7:17. doi: 10.1186/1744-859X-7-17. Ann Gen Psychiatry. 2008. PMID: 18782433 Free PMC article.
Seasonal adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational GEPAT-SMART study.
Deftereos SN, Koutlas E, Koutsouraki E, Kyritsis A, Papathanassopoulos P, Fakas N, Tsimourtou V, Vlaikidis N, Tavernarakis A, Voumvourakis K, Arvanitis M, Sakellariou D, DeLorenzo F. Deftereos SN, et al. Among authors: vlaikidis n. BMC Neurol. 2018 Nov 6;18(1):186. doi: 10.1186/s12883-018-1179-0. BMC Neurol. 2018. PMID: 30400884 Free PMC article.
The STAR Study: a real-world, international, observational study of the safety and tolerability of, and adherence to, serum-free subcutaneous interferon β-1a in patients with relapsing multiple sclerosis.
Hupperts R, Ghazi-Visser L, Martins Silva A, Arvanitis M, Kuusisto H, Marhardt K, Vlaikidis N; STAR Study Group. Hupperts R, et al. Among authors: vlaikidis n. Clin Ther. 2014 Dec 1;36(12):1946-1957. doi: 10.1016/j.clinthera.2014.04.002. Epub 2014 May 5. Clin Ther. 2014. PMID: 24811754 Free article.
Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA).
Hadjigeorgiou G, Dardiotis E, Tsivgoulis G, Doskas T, Petrou D, Makris N, Vlaikidis N, Thomaidis T, Kyritsis A, Fakas N, Treska X, Karageorgiou C, Sotirli S, Giannoulis C, Papadimitriou D, Mylonas I, Kouremenos E, Vlachos G, Georgiopoulos D, Mademtzoglou D, Vikelis M, Zintzaras E. Hadjigeorgiou G, et al. Among authors: vlaikidis n. PLoS One. 2014 Nov 24;9(11):e113933. doi: 10.1371/journal.pone.0113933. eCollection 2014. PLoS One. 2014. PMID: 25419842 Free PMC article.
30 results